Vascular calcification: The killer of patients with chronic kidney disease

Journal of the American Society of Nephrology

Volumn 20, Issue 7, 2009, Pages 1453-1464

  Mizobuchi, Masahide ^a   Towler, Dwight ^a   Slatopolsky, Eduardo ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

22 OXACALCITRIOL; 4 CARBOXYGLUTAMIC ACID; CALCITRIOL; CALCIUM; CALCIUM PHOSPHATE; DOXERCALCIFEROL; ELASTIN; FETUIN A; OSTEOCALCIN; OSTEOGENIC PROTEIN 1; OSTEOPONTIN; OSTEOPROTEGERIN; PARICALCITOL; PHOSPHORUS; PYROPHOSPHATE; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; UREMIC TOXIN; VITAMIN D;

BLOOD VESSEL CALCIFICATION; BONE DEVELOPMENT; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CELL PROLIFERATION; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DRUG INHIBITION; DRUG MEGADOSE; DYSLIPIDEMIA; HUMAN; HYPERPHOSPHATEMIA; INFLAMMATION; MINERALIZATION; MORTALITY; NONHUMAN; OSTEOBLAST; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SECONDARY HYPERPARATHYROIDISM; UPREGULATION; UREMIA;

EID: 67649678424     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008070692     Document Type: Review

References (148)

1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32: S112-S119, 1998 (Pubitemid 28527268)
2. London GM, Guerin AP, Marchais S, Metivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18:1731-1740, 2003 (Pubitemid 37098542)
3. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38: 938-942, 2001 (Pubitemid 34258697)
4. Keelan PC, Bielak LF, Ashai K, Jamjoum LS, Denktas AE, Rumberger JA, Sheedy PF II, Peyser PA, Schwartz RS: Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation 104: 412-417, 2001 (Pubitemid 32678270)
5. Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, Sanderson JE: Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study. J Am Soc Nephrol 14: 159-168, 2003 (Pubitemid 36032720)
6. Wilson PW, Kauppila LI, O'Donnell CJ, Kiel DP, Hannan M, Polak JM, Cupples LA: Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 103: 1529-1534, 2001 (Pubitemid 32226260)
7. Goodman WG, London G, Amann K, Block GA, Giachelli C, Hruska KA, Ketteler M, Levin A, Massy Z, McCarron DA, Raggi P, Shanahan CM, Yorioka N: Vascular calcification in chronic kidney disease. Am J Kidney Dis 43: 572-579, 2004 (Pubitemid 38298218)
8. Shroff RC, Shanahan CM: The vascular biology of calcification. Semin Dial 20: 103-109, 2007
9. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ: Atherosclerosis: Basic mechanisms - Oxidation, inflammation, and genetics. Circulation 91: 2488-2496, 1995
10. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004 (Pubitemid 39031360)
11. Cozzolino M, Dusso AS, Slatopolsky E: Role of calcium-phosphate product and boneassociated proteins on vascular calcification in renal failure. J Am Soc Nephrol 12: 2511-2516, 2001 (Pubitemid 33021131)
12. Ganesh SK, Stack AG, Levin NW, Levin NW, Hulbert-Shearon T, Port FK: Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12: 2131-2138, 2001 (Pubitemid 32880350)
13. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL: Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91: 1800 - 1809, 1993 (Pubitemid 23127387)
14. Hirota S, Imakita M, Kohri K, Ito A, Morii E, Adachi S, Kim HM, Kitamura Y, Yutani C, Nomura S: Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques: A possible association with calcification. Am J Pathol 143: 1003-1008, 1993 (Pubitemid 24070540)
15. Iimura T, Oida S, Takeda K, Maruoka Y, Sasaki S: Changes in homeobox-containing gene expression during ectopic bone formation induced by bone morphogenetic protein. Biochem Biophys Res Commun 201: 980-987, 1994 (Pubitemid 24206968)
16. Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K: Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest 92: 2814-2820, 1993 (Pubitemid 24006549)
17. O'Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, Giachelli CM: Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb 14: 1648-1656, 1994 (Pubitemid 24312226)
18. Schoppet M, Al-Fakhri N, Franke FE, Katz N, Barth PJ, Maisch B, Preissner KT, Hofbauer LC: Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Monckeberg's sclerosis and atherosclerosis. J Clin Endocrinol Metab 89: 4104-4112, 2004 (Pubitemid 39071519)
19. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL: High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 93: 2393-2402, 1994 (Pubitemid 24177151)
20. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME: Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: Evidence for smooth muscle cell-mediated vascular calcification. Circulation 100: 2168-2176, 1999
21. Speer MY, McKee MD, Guldberg RE, Liaw L, Yang HY, Tung E, Karsenty G, Giachelli CM: Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: Evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 196: 1047-1055, 2002 (Pubitemid 35231763)
22. Tyson KL, Reynolds JL, McNair R, Zhang Q, Weissberg PL, Shanahan CM: Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 23: 489-494, 2003 (Pubitemid 36337227)
23. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM: Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 92: 1686-1696, 1993 (Pubitemid 23304531)
24. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT: Diffuse calcification in human coronary arteries: Association of osteopontin with atherosclerosis. J Clin Invest 94: 1597-1604, 1994 (Pubitemid 24309882)
25. Derici U, El Nahas AM: Vascular calcifications in uremia: Old concepts and new insights. Semin Dial 19: 60-68, 2006
26. Giachelli CM, Speer MY, Li X, Rajachar RM, Yang H: Regulation of vascular calcification: Roles of phosphate and osteopontin. Circ Res 96: 717-722, 2005
27. Johnson RC, Leopold JA, Loscalzo J: Vascular calcification: Pathobiological mechanisms and clinical implications. Circ Res 99: 1044-1059, 2006 (Pubitemid 44729928)
28. Moe SM, Chen NX: Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 95: 560-567, 2004 (Pubitemid 39274370)
29. Block GA, Port FK: Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management. Am J Kidney Dis 35: 1226-1237, 2000 (Pubitemid 30354431)
30. Marco MP, Craver L, Betriu A, Belart M, Fibla J, Ferná ndez E: Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population. Kidney Int Suppl S111-S114, 2003 (Pubitemid 36608935)
31. Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT: The Kidney Disease Outcomes Quality Initiative (K/ DOQI) Guideline for Bone Metabolism and Disease in CKD: Association with mortality in dialysis patients. Am J Kidney Dis 46: 925-932, 2005 (Pubitemid 41505468)
32. Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK: Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int 67: 1179-1187, 2005 (Pubitemid 41623345)
33. Goldsmith DJ, Covic A, Sambrook PA, Ackrill P: Vascular calcification in long-term haemodialysis patients in a single unit: A retrospective analysis. Nephron 77: 37-43, 1997 (Pubitemid 27395339)
34. Guerin AP, London GM, Marchais SJ, Metivier F: Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15: 1014-1021, 2000 (Pubitemid 30410374)
35. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342: 1478-1483, 2000 (Pubitemid 30318271)
36. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F: Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106: 100-105, 2002 (Pubitemid 34747448)
37. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM: Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 71: 438-441, 2007 (Pubitemid 46303553)
38. Braun J, Asmus HG, Holzer H, Brunkhorst R, Krause R, Schulz W, Neumayer HH, Raggi P, Bommer J: Long-term comparison of a calcium-free phosphate binder and calcium carbonate: Phosphorus metabolism and cardiovascular calcification. Clin Nephrol 62: 104-115, 2004 (Pubitemid 39162762)
39. Chertow GM, Raggi P, Chasan-Taber S, Bommer J, Holzer H, Burke SK: Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant 19: 1489-1496, 2004 (Pubitemid 38786743)
40. Doherty TM, Tang W, Dascalos S, Watson KE, Demer LL, Shavelle RM, Detrano RC: Ethnic origin and serum levels of 1alpha,25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. Circulation 96: 1477-1481, 1997 (Pubitemid 27375339)
41. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, Demer LL: Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96: 1755-1760, 1997 (Pubitemid 27400730)
42. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70: 771-780, 2006 (Pubitemid 44215354)
43. Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S, Ishimura E, Miki T, Tabata T, Nishizawa Y: Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant 19: 179-184, 2004 (Pubitemid 38072630)
44. Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R: Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349: 446-456, 2003 (Pubitemid 36910023)
45. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernán MA, Camargo CA Jr, Thadhani R: Activated injectable vitamin D and hemodialysis survival: A historical cohort study. J Am Soc Nephrol 16: 1115-1125, 2005
46. Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, Zager PG: Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 70: 1858-1865, 2006 (Pubitemid 44684819)
47. Slatopolsky E, Finch JL, Brown AJ, Ritter CS, Mizobuchi M, Plum LA, Clagett-Dame M, Sicinski RR, DeLuca HF: Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism. J Bone Miner Res 22: 686-694, 2007 (Pubitemid 351339096)
48. Levy RJ, Gundberg C, Scheinman R: The identification of the vitamin K-dependent bone protein osteocalcin as one of the gamma-carboxyglutamic acid containing proteins present in calcified atherosclerotic plaque and mineralized heart valves. Atherosclerosis 46: 49-56, 1983 (Pubitemid 13180784)
49. Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, Tordoir JH, Spronk HM, Vermeer C, Daemen MJ: Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21: 1998-2003, 2001
50. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ: Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765-771, 1997 (Pubitemid 27516179)
51. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR: Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89: 773-779, 1997 (Pubitemid 27516180)
52. Franceschi RT, Xiao G: Regulation of the osteoblast-specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways. J Cell Biochem 88: 446-454, 2003 (Pubitemid 36158266)
53. Chen NX, O'Neill KD, Duan D, Moe SM: Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int 62: 1724-1731, 2002 (Pubitemid 35286280)
54. Jono S, McKee MD, Murry CE, Shioi A, Morii HO: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87: E10-E17, 2000
55. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, Schinke T, Karsenty G, Giachelli CM: Smooth muscle cell phenotypic transition associated with calcification: Upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 89: 1147-1154, 2001 (Pubitemid 34627872)
56. Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS: Bone formation and inflammation in cardiac valves. Circulation 103: 1522-1528, 2001
57. Towler DA: Vascular biology and bone formation: Hints from HIF. J Clin Invest 117: 1477-1480, 2007 (Pubitemid 46871330)
58. Janzen J, Vuong PN: Arterial calcifications: Morphological aspects and their pathological implications. Z Kardiol 90[Suppl 3]: 6-11, 2001 (Pubitemid 32291159)
59. Jacob MP: Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed Pharmacother 57: 195-202, 2003 (Pubitemid 36897685)
60. Sherratt MJ, Wess TJ, Baldock C, Ashworth JL, Sherratt MJ, Shuttleworth CA: Fibrillinrich microfibrils of the extracellular matrix: Ultrastructure and assembly. Micron 32: 185-200, 2001
61. Basalyga DM, Simionescu DT, Xiong W, Baxter BT, Starcher BC, Vyavahare NR: Elastin degradation and calcification in an abdominal aorta injury model: Role of matrix metalloproteinases. Circulation 110: 3480-3487, 2004 (Pubitemid 39602227)
62. Mecham RP, Broekelmann TJ, Fliszar CJ, Shapiro SD, Welgus HG, Senior RM: Elastin degradation by matrix metalloproteinases: Cleavage site specificity and mechanisms of elastolysis. J Biol Chem 272: 18071-18076, 1997 (Pubitemid 27306388)
63. Lee JS, Basalyga DM, Simionescu A, Isenburg JC, Simionescu DT, Vyavahare NR: Elastin calcification in the rat subdermal model is accompanied by up-regulation of degradative and osteogenic cellular responses. Am J Pathol 168: 490-498, 2006 (Pubitemid 43271147)
64. Maeda S, Hayashi M, Komiya S, Imamura T, Miyazono K: Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO J 23: 552-563, 2004 (Pubitemid 38282387)
65. Jeziorska M: Transforming growth factorbetas and CD105 expression in calcification and bone formation in human atherosclerotic lesions. Z Kardiol 90[Suppl 3]: 23-26, 2001 (Pubitemid 32291162)
66. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL: TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast- like vascular cells to calcify. J Clin Invest 93:2106-2113, 1994 (Pubitemid 24143091)
67. Mizobuchi M, Ogata H, Hatamura I, Koiwa F, Saji F, Shiizaki K, Negi S, Kinugasa E, Ooshima A, Koshikawa S, Akizawa T: Up-regulation of Cbfa1 and Pit-1 in calcified artery of uraemic rats with severe hyperphosphataemia and secondary hyperparathyroidism. Nephrol Dial Transplant 21: 911-916, 2006
68. Li X, Yang HY, Giachelli CM: Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 98: 905-912, 2006 (Pubitemid 43755243)
69. Lomashvili K, Garg P, O'Neill WC: Chemical and hormonal determinants of vascular calcification in vitro. Kidney Int 69: 1464-1470, 2006
70. Yang H, Curinga G, Giachelli CM: Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int 66: 2293-2299, 2004 (Pubitemid 41115292)
71. Molostvov G, James S, Fletcher S, Bennett J, Lehnert H, Bland R, Zehnder D: Extracellular calcium-sensing receptor is functionally expressed in human artery. Am J Physiol Renal Physiol 293: F946-F955, 2007 (Pubitemid 47403367)
72. Kim KM: Apoptosis and calcification. Scanning Microsc 9: 1137-1175, discussion 1175-11138, 1995
73. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL: Apoptosis regulates human vascular calcification in vitro: Evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 87: 1055-1062, 2000 (Pubitemid 30949223)
74. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen- Dechent W, Weissberg PL, Shanahan CM: Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15: 2857-2867, 2004 (Pubitemid 41103395)
75. Reynolds JL, Skepper JN, McNair R, Kasama T, Gupta K, Weissberg PL, Jahnen-Dechent W, Shanahan CM: Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 16: 2920-2930, 2005 (Pubitemid 44743490)
76. Moe SM, Duan D, Doehle BP, O'Neill KD, Chen NX: Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 63: 1003-1011, 2003 (Pubitemid 36315578)
77. Chen NX, Duan D, O'Neill KD, Wolisi GO, Koczman JJ, Laclair R, Moe SM: The mechanisms of uremic serum-induced expression of bone matrix proteins in bovine vascular smooth muscle cells. Kidney Int 70: 1046-1053, 2006 (Pubitemid 44344074)
78. Bostrom K, Tsao D, Shen S, Wang Y, Demer LL: Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem 276: 14044-14052, 2001 (Pubitemid 37391788)
79. Annuk M, Fellstrom B, Akerblom O, Zilmer K, Vihalemm T, Zilmer M: Oxidative stress markers in pre-uremic patients. Clin Nephrol 56: 308-314, 2001 (Pubitemid 32923165)
80. Annuk M, Zilmer M, Lind L, Linde T, Fellström B: Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol 12: 2747-2752, 2001 (Pubitemid 33115422)
81. Taccone-Gallucci M, Lubrano R, Del Principe D, Menichelli A, Giordani M, Citti G, Morosetti M, Meloni C, Mazzarella V, Meschini L, Tozzo C, Elli M, Giardini O, Casciani CU: Platelet lipid peroxidation in haemodialysis patients: Effects of vitamin E supplementation. Nephrol Dial Transplant 4: 975-978, 1989 (Pubitemid 20050403)
82. Fillit H, Elion E, Sullivan J, Sherman R, Zabriskie JB: Thiobarbituric acid reactive material in uremic blood. Nephron 29: 40-43, 1981 (Pubitemid 12241811)
83. Mody N, Parhami F, Sarafian TA, Demer LL: Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 31: 509-519, 2001 (Pubitemid 32728438)
84. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL: Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation: A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17: 680-687, 1997 (Pubitemid 27169128)
85. Byon CH, Javed A, Dai Q, Kappes JC, Clemens TL, Darley-Usmar VM, McDonald JM, Chen Y: Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem 283: 15319-15327, 2008
86. Liberman M, Bassi E, Martinatti MK, Lario FC, Wosniak J Jr, Pomerantzeff PM, Laurindo FR: Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol 28: 463-470, 2008
87. Shioi A, Katagi M, Okuno Y, Mori K, Jono S, Koyama H, Nishizawa Y: Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: Roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res 91: 9-16, 2002 (Pubitemid 34778936)
88. Tintut Y, Patel J, Territo M, Saini T, Parhami F, Demer LL: Monocyte/macrophage regulation of vascular calcification in vitro. Circulation 105: 650-655, 2002 (Pubitemid 34123443)
89. Tintut Y, Patel J, Parhami F, Demer LL: Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102:2636-2642, 2000 (Pubitemid 30846073)
90. Tintut Y, Parhami F, Bostrom K, Jackson SM, Demer LL: cAMP stimulates osteoblast- like differentiation of calcifying vascular cells: Potential signaling pathway for vascular calcification. J Biol Chem 273: 7547-7553, 1998 (Pubitemid 28152780)
91. Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Boström K, Demer LL: Multilineage potential of cells from the artery wall. Circulation 108: 2505-2510, 2003 (Pubitemid 37444413)
92. Al-Aly Z, Shao JS, Lai CF, Huang E, Cai J, Behrmann A, Cheng SL, Towler DA: Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha dependent signals in diabetic Ldlr-/- mice. Arterioscler Thromb Vasc Biol 27: 2589-2596, 2007 (Pubitemid 350158910)
93. Kirton JP, Crofts NJ, George SJ, Brennan K, Canfield AE: Wnt/beta-catenin signaling stimulates chondrogenic and inhibits adipogenic differentiation of pericytes: Potential relevance to vascular disease. Circ Res 101: 581-589, 2007 (Pubitemid 351325875)
94. Khosla S, Eghbali-Fatourechi GZ: Circulating cells with osteogenic potential. Ann N Y Acad Sci 1068: 489-497, 2006 (Pubitemid 43824177)
95. Wolf G, Chen S, Han DC, Ziyadeh FN: Leptin and renal disease. Am J Kidney Dis 39: 1-11, 2002 (Pubitemid 34062489)
96. Parhami F, Tintut Y, Ballard A, Fogelman AM, Demer LL: Leptin enhances the calcification of vascular cells: Artery wall as a target of leptin. Circ Res 88: 954-960, 2001 (Pubitemid 32441475)
97. Chen NX, Duan D, O'Neill KD, Moe SM: High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant 21: 3435-3442, 2006 (Pubitemid 44817092)
98. Mori K, Shioi A, Jono S, Nishizawa Y, Morii H: Dexamethasone enhances in vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19: 2112-2118, 1999 (Pubitemid 29422242)
99. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386: 78-81, 1997 (Pubitemid 27130923)
100. Schurgers LJ, Teunissen KJ, Knapen MH, Kwaijtaal M, van Diest R, Appels A, Reutelingsperger CP, Cleutjens JP, Vermeer C: Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: Undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 25: 1629-1633, 2005 (Pubitemid 41098932)
101. Price PA, Thomas GR, Pardini AW, Figueira WF, Caputo JM, Williamson MK: Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma- carboxyglutamic acid protein in the serum of etidronate-treated rats. J Biol Chem 277: 3926-3934, 2002 (Pubitemid 34968645)
102. Roy ME, Nishimoto SK: Matrix Gla protein binding to hydroxyapatite is dependent on the ionic environment: Calcium enhances binding affinity but phosphate and magnesium decrease affinity. Bone 31: 296-302, 2002 (Pubitemid 34814964)
103. Yao Y, Shahbazian A, Boström KI: Proline and gamma-carboxylated glutamate residues in matrix Gla protein are critical for binding of bone morphogenetic protein-4. Circ Res 102: 1065-1074, 2008 (Pubitemid 351667860)
104. Scatena M, Liaw L, Giachelli CM. Osteopontin: A multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27: 2302-2309, 2007 (Pubitemid 350203943)
105. Wada T, McKee MD, Steitz S, Giachelli CM: Calcification of vascular smooth muscle cell cultures: Inhibition by osteopontin. Circ Res 84: 166-178, 1999 (Pubitemid 29070112)
106. Jono S, Peinado C, Giachelli CM: Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 275: 20197-20203, 2000 (Pubitemid 30441631)
107. Qin X, Corriere MA, Matrisian LM, Guzman RJ: Matrix metalloproteinase inhibition attenuates aortic calcification. Arterioscler Thromb Vasc Biol 26: 1510-1516, 2006 (Pubitemid 44288976)
108. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176, 1998 (Pubitemid 28180851)
109. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS: Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12: 1260-1268, 1998 (Pubitemid 28213402)
110. Bennett BJ, Scatena M, Kirk EA, Rattazzi M, Varon RM, Averill M, Schwartz SM, Giachelli CM, Rosenfeld ME: Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice. Arterioscler Thromb Vasc Biol 26: 2117-2124, 2006 (Pubitemid 44253797)
111. Orita Y, Yamamoto H, Kohno N, Sugihara M, Honda H, Kawamata S, Mito S, Soe NN, Yoshizumi M: Role of osteoprotegerin in arterial calcification: Development of new animal model. Arterioscler Thromb Vasc Biol 27: 2058-2064, 2007 (Pubitemid 47312318)
112. Morony S, Tintut Y, Zhang Z, Cattley RC, Van G, Dwyer D, Stolina M, Kostenuik PJ, Demer LL: Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice. Circulation 117: 411-420, 2008.
113. Ketteler M: Fetuin-A and extraosseous calcification in uremia. Curr Opin Nephrol Hypertens 14: 337-342, 2005 (Pubitemid 40863070)
114. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W: The serum protein alpha 2-Heremans-Schmid glycoprotein/ fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112: 357-366, 2003 (Pubitemid 38063764)
115. Chen NX, O'Neill KD, Chen X, Duan D, Wang E, Sturek MS, Edwards JM, Moe SM: Fetuin-A uptake in bovine vascular smooth muscle cells is calcium dependent and mediated by annexins. Am J Physiol Renal Physiol 292: F599-F606, 2007 (Pubitemid 46220527)
116. Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Millá n JL: Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: An integrated model of the pathogenesis of mineralization disorders. Am J Pathol 164: 1199-1209, 2004 (Pubitemid 38387787)
117. Rutsch F, Ruf N, Vaingankar S, Toliat MR, Suk A, Höhne W, Schauer G, Lehmann M, Roscioli T, Schnabel D, Epplen JT, Knisely A, Superti-Furga A, McGill J, Filippone M, Sinaiko AR, Vallance H, Hinrichs B, Smith W, Ferre M, Terkeltaub R, Nürnberg P: Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification. Nat Genet 34: 379-381, 2003 (Pubitemid 36935330)
118. Johnson K, Polewski M, van Etten D, Terkeltaub R: Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1-/- mice. Arterioscler Thromb Vasc Biol 25: 686-691, 2005 (Pubitemid 40463854)
119. Lomashvili KA, Cobbs S, Hennigar RA, Hardcastle KI, O'Neill WC: Phosphate-induced vascular calcification: Role of pyrophosphate and osteopontin. J Am Soc Nephrol 15: 1392-1401, 2004 (Pubitemid 38679664)
120. Towler DA: Inorganic pyrophosphate: A paracrine regulator of vascular calcification and smooth muscle phenotype. Arterioscler Thromb Vasc Biol 25: 651-654, 2005 (Pubitemid 40463849)
121. Abedin M, Lim J, Tang TB, Park D, Demer LL, Tintut Y: N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator- activated receptor-gamma pathways. Circ Res 98: 727-729, 2006 (Pubitemid 43755256)
122. Radcliff K, Tang TB, Lim J, Zhang Z, Abedin M, Demer LL, Tintut Y: Insulin-like growth factor-1 regulates proliferation and osteo-blastic differentiation of calcifying vascular cells via extracellular signal-related protein kinase and phosphatidylinositol 3-kinase pathways. Circ Res 96: 398-400, 2005 (Pubitemid 40354532)
123. Galvin KM, Donovan MJ, Lynch CA, Meyer RI, Paul RJ, Lorenz JN, Fairchild-Huntress V, Dixon KL, Dunmore JH, Gimbrone MA Jr, Falb D, Huszar D: A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet 24: 171-174, 2000 (Pubitemid 30094719)
124. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390: 45-51, 1997 (Pubitemid 27494749)
125. Razzaque MS, St-Arnaud R, Taguchi T, Lanske B: FGF-23, vitamin D and calcification: The unholy triad. Nephrol Dial Transplant 20: 2032-2035, 2005 (Pubitemid 41510074)
126. Spicer SS, Lewis SE, Tashian RE, Schulte BA: Mice carrying a CAR-2 null allele lack carbonic anhydrase II immunohistochemically and show vascular calcification. Am J Pathol 134: 947-954, 1989 (Pubitemid 19111260)
127. Tomson C: Vascular calcification in chronic renal failure. Nephron Clin Pract 93: c124-c130, 2003
128. Somjen D, Weisman Y, Kohen F, Gayer B, Limor R, Sharon O, Jaccard N, Knoll E, Stern N: 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 111: 1666-1671, 2005 (Pubitemid 40525167)
129. Inoue T, Kawashima H: 1,25-Dihydroxyvitamin D3 stimulates 45Ca2+-uptake by cultured vascular smooth muscle cells derived from rat aorta. Biochem Biophys Res Commun 152: 1388-1394, 1988
130. Rajasree S, Umashankar PR, Lal AV, Sarma PS, Kartha CC: 1,25-Dihydroxyvitamin D3 receptor is upregulated in aortic smooth muscle cells during hypervitaminosis D. Life Sci 70: 1777-1788, 2002 (Pubitemid 34178363)
131. Wu-Wong JR, Nakane M, Ma J, Ruan X, Kroeger PE: Effects of vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis 186: 20-28, 2006
132. Carthy EP, Yamashita W, Hsu A, Ooi BS: 1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth. Hypertension 13: 954-959, 1989 (Pubitemid 19157996)
133. Cardus A, Parisi E, Gallego C, Aldea M, Fernández E, Valdivielso JM: 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney Int 69: 1377-1384, 2006
134. Yamamoto T, Kozawa O, Tanabe K, Akamatsu S, Matsuno H, Dohi S, Hirose H, Uematsu T: 1,25-Dihydroxyvitamin D3 stimulates vascular endothelial growth factor release in aortic smooth muscle cells: Role of p38 mitogen-activated protein kinase. Arch Biochem Biophys 398: 1-6, 2002 (Pubitemid 34848318)
135. Rebsamen MC, Sun J, Norman AW, Liao JK: 1Alpha, 25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circ Res 91: 17-24, 2002 (Pubitemid 34778937)
136. Cardus A, Panizo S, Parisi E, Fernandez E, Valdivielso JM: Differential effects of vitamin D analogs on vascular calcification. J Bone Miner Res 22: 860-866, 2007 (Pubitemid 351339746)
137. Jono S, Nishizawa Y, Shioi A, Morii H: 1,25- Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 98: 1302-1306, 1998 (Pubitemid 28443394)
138. Wolisi GO, Moe SM: The role of vitamin D in vascular calcification in chronic kidney disease. Semin Dial 18: 307-314, 2005 (Pubitemid 41159582)
139. Henley C, Colloton M, Cattley RC, Shatzen E, Towler DA, Lacey D, Martin D: 1,25- Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism. Nephrol Dial Transplant 20: 1370-1377, 2005 (Pubitemid 41430610)
140. Hirata M, Katsumata K, Endo K, Fukushima N, Ohkawa H, Fukagawa M: In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3. Nephrol Dial Transplant 18: 1770-1776, 2003 (Pubitemid 37098547)
141. Mizobuchi M, Finch JL, Martin DR, Slatopolsky E: Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. Kidney Int 72: 709-715, 2007 (Pubitemid 47373790)
142. Wu-Wong JR, Noonan W, Ma J, Dixon D, Nakane M, Bolin AL, Koch KA, Postl S, Morgan SJ, Reinhart GA: Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification. J Pharmacol Exp Ther 318: 90-98, 2006 (Pubitemid 43920745)
143. Paredes R, Arriagada G, Cruzat F, Villagra A, Olate J, Zaidi K, van Wijnen A, Lian JB, Stein GS, Stein JL, Montecino M: Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells. Mol Cell Biol 24: 8847-8861, 2004 (Pubitemid 39313891)
144. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC: Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15: 1943-1951, 2004 (Pubitemid 38822076)
145. Craver L, Marco MP, Martinez I, Rue M, Borràs M, Martín ML, Sarró F, Valdivielso JM, Fernández E: Mineral metabolism parameters throughout chronic kidney disease stages 1-5: Achievement of K/DOQI target ranges. Nephrol Dial Transplant 22: 1171-1176, 2007 (Pubitemid 46523434)
146. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL: Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney Int 71: 31-38, 2007 (Pubitemid 44967731)
147. Mathew S, Tustison KS, Sugatani T, Chaudhary LR, Rifas L, Hruska KA: The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol 19: 1092-1105, 2008
148. Shao JS, Aly ZA, Chen SL, Cheng SL, Cai J, Huang E, Behrmann A, Towler DA: Vascular Bmp Msx2 Wnt signalling and oxidative stress in arterial calcification. Ann N Y Acad Sci 1117: 40-50, 2007 (Pubitemid 350191291)